Journal of Internal Medicine Concepts & Practice ›› 2022, Vol. 17 ›› Issue (03): 186-189.doi: 10.16138/j.1673-6087.2022.03.002
• Experts forum • Previous Articles Next Articles
Received:2021-11-08
Online:2022-05-30
Published:2022-08-09
CLC Number:
| [1] |
FitzGerald O, Ogdie A, Chandran V, et al. Psoriatic arthritis[J]. Nat Rev Dis Primers, 2021, 7(1): 59.
doi: 10.1038/s41572-021-00293-y pmid: 34385474 |
| [2] |
Gladman DD, Antoni C, Mease P, et al. Psoriatic arthritis: epidemiology, clinical features, course, and outcome[J]. Ann Rheum Dis, 2005, 64 Suppl 2:ii14-ii17.
doi: 10.1136/ard.2004.032482 pmid: 15708927 |
| [3] |
van der Heijde D, Gladman DD, Kavanaugh A, et al. Assessing structural damage progression in psoriatic arthritis and its role as an outcome in research[J]. Arthritis Res Ther, 2020, 22(1): 18.
doi: 10.1186/s13075-020-2103-8 URL |
| [4] |
McHugh NJ, Balachrishnan C, Jones SM. Progression of peripheral joint disease in psoriatic arthritis: a 5-yr prospective study[J]. Rheumatology (Oxford), 2003, 42(6): 778-783.
doi: 10.1093/rheumatology/keg217 URL |
| [5] |
Charlton R, Green A, Shaddick G, et al. Risk of type 2 diabetes and cardiovascular disease in an incident cohort of people with psoriatic arthritis: a population-based cohort study[J]. Rheumatology(Oxford), 2019, 58(1): 144-148.
doi: 10.1093/rheumatology/key286 URL |
| [6] |
Favarato MH, Mease P, Gonçalves CR, et al. Hypertension and diabetes significantly enhance the risk of cardiovascular disease in patients with psoriatic arthritis[J]. Clin Exp Rheumatol, 2014, 32(2): 182-187.
pmid: 24480317 |
| [7] |
Szentpetery A, Healy GM, Brady D, et al. Higher coronary plaque burden in psoriatic arthritis is independent of metabolic syndrome and associated with underlying disease severity[J]. Arthritis Rheumatol, 70(3): 396-407.
doi: 10.1002/art.40389 URL |
| [8] |
Rosen CF, Mussani F, Chandran V, et al. Patients with psoriatic arthritis have worse quality of life than those with psoriasis alone[J]. Rheumatology, 2012, 51(3):571-576.
doi: 10.1093/rheumatology/ker365 URL |
| [9] |
Chen Z, Xu Y, Chen M, et al. Gout augments the risk of cardiovascular disease in patients with psoriasis[J]. Front Immunol, 2021, 12: 703119.
doi: 10.3389/fimmu.2021.703119 URL |
| [10] | 丁晓岚, 王婷琳, 沈佚葳, 等. 中国六省市银屑病流行病学调查[J]. 中国皮肤性病学杂志, 2010, 24(7): 598-601. |
| [11] |
Reich K, Krüger K, Mössner R, et al. Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis[J]. Br J Dermatol, 2009, 160(5): 1040-1047.
doi: 10.1111/j.1365-2133.2008.09023.x pmid: 19210498 |
| [12] | Guillen Astete CA, Gaite Gonzalez I, Zurita Prada PA, et al. Delay and diagnostic pathway of patients with psoriatic arthritis in Spain[J]. Reumatol Clin (Engl Ed), 2020, 17(9): 525-529. |
| [13] |
Karmacharya P, Wright K, Achenbach SJ, et al. Diagnostic delay in psoriatic arthritis[J]. J Rheumatol, 2021, 48(9): 1410-1416.
doi: 10.3899/jrheum.201199 pmid: 33589556 |
| [14] |
Cui R, Chen M, Li X, et al. Assessment of four screening tools and retrieval of key questions to detect undiagnosed psoriatic arthritis in Chinese patients with psoriasis[J]. J Dermatol, 2022, 49(6): 615-623.
doi: 10.1111/1346-8138.16355 URL |
| [15] |
Tinazzi I, Adami S, Zanolin EM, et al. The early psoriatic arthritis screening questionnaire: a simple and fast method for the identification of arthritis in patients with psoriasis[J]. Rheumatology, 2012, 51(11): 2058-2063.
doi: 10.1093/rheumatology/kes187 pmid: 22879464 |
| [16] |
Ibrahim GH, Buch MH, Lawson C, et al. Evaluation of an existing screening tool for psoriatic arthritis in people with psoriasis and the development of a new instrument: the Psoriasis Epidemiology Screening Tool (PEST) questionnaire[J]. Clin Exp Rheumatol, 2009, 27(3): 469-474.
pmid: 19604440 |
| [17] |
Lindqvist UR, Alenius GM, Husmark T, et al. The Swedish early psoriatic arthritis register- 2-year followup[J]. J Rheumatol, 2008, 35(4): 668-673.
pmid: 18278834 |
| [18] |
Kane D, Stafford L, Bresnihan B, et al. A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience[J]. Rheumatology, 2003, 42(12): 1460-1468.
doi: 10.1093/rheumatology/keg384 URL |
| [19] |
Kane D, Pathare S. Early psoriatic arthritis[J]. Rheum Dis Clin North Am, 2005, 31(4): 641-657.
doi: 10.1016/j.rdc.2005.07.009 URL |
| [20] |
Haroon M, Gallagher P, FitzGerald O. Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis[J]. Ann Rheum Dis, 2015, 74(6): 1045-1050.
doi: 10.1136/annrheumdis-2013-204858 URL |
| [21] | Weisman MH, Witter JP, Reveille JD. The prevalence of inflammatory back pain: population-based estimates from the US National Health and Nutrition Examination Survey, 2009-10[J]. Ann Rheum Di, 2013, 72(3): 369-373. |
| [22] | Dai SM, Han XH, Zhao DB, et al. Prevalence of rheumatic symptoms, rheumatoid arthritis, ankylosing spondylitis, and gout in Shanghai, China[J]. J Rheumatol, 2003, 30(10): 2245-2251. |
| [23] |
Xiang YJ, Dai SM. Prevalence of rheumatic diseases and disability in China[J]. Rheumatol Int, 2009, 29(5): 481-490.
doi: 10.1007/s00296-008-0809-z URL |
| [24] |
Kingsley GH, Kowalczyk A, Taylor H, et al. A randomized placebo-controlled trial of methotrexate in psoriatic arthritis[J]. Rheumatology (Oxford), 2012, 51(8):1368-1377.
doi: 10.1093/rheumatology/kes001 URL |
| [25] |
Ramiro S, Smolen JS, Landewé R, et al. Pharmacological treatment of psoriatic arthritis: a systematic literature review for the 2015 update of the EULAR recommendations for the management of psoriatic arthritis[J]. Ann Rheum Dis, 2016, 75(3): 490-498.
doi: 10.1136/annrheumdis-2015-208466 pmid: 26660203 |
| [26] |
Acosta Felquer ML, Coates LC, Soriano ER, et al. Drug therapies for peripheral joint disease in psoriatic arthritis: a systematic review[J]. J Rheumatol, 2014, 41(11): 2277-2285.
doi: 10.3899/jrheum.140876 pmid: 25362711 |
| [27] |
Kaltwasser JP, Nash P, Gladman D, et al. Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial[J]. Arthritis Rheum, 2004, 50(6): 1939-1950.
doi: 10.1002/art.20253 URL |
| [28] |
Zardin-Moraes M, da Silva ALFA, Saldanha C, et al. Prevalence of psoriatic arthritis patients achieving minimal disease activity in real-world studies and randomized clinical trials[J]. J Rheumatol, 2020, 47(6): 839-846.
doi: 10.3899/jrheum.190677 pmid: 31575702 |
| [29] |
Chen M, Zhang H, Chen Z, et al. Perceptions of rheumatologists on diagnosis of psoriatic arthritis in China[J]. Front Immunol, 2021, 12:733708.
doi: 10.3389/fimmu.2021.733708 URL |
| [1] | ZHOU Yi, CHEN Ying, CHEN Erzhen. Research progress of thyroid hormone on organ function maintenance in sepsis [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(05): 408-412. |
| [2] | . [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(04): 339-343. |
| [3] | . [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(03): 262-266. |
| [4] | . [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(03): 258-261. |
| [5] | . [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(03): 202-207. |
| [6] | . [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(03): 181-185. |
| [7] | . [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(03): 190-194. |
| [8] | . [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(03): 267-272. |
| [9] | . [J]. Journal of Internal Medicine Concepts & Practice, 2021, 16(04): 270-271. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
